DK0934073T3 - Farmaceutisk sammensætning indeholdende komplementproteiner til behandling af Heliobacter infektioner og en fremgangsmåde til fremstilling af sammensætningen - Google Patents

Farmaceutisk sammensætning indeholdende komplementproteiner til behandling af Heliobacter infektioner og en fremgangsmåde til fremstilling af sammensætningen

Info

Publication number
DK0934073T3
DK0934073T3 DK97929322T DK97929322T DK0934073T3 DK 0934073 T3 DK0934073 T3 DK 0934073T3 DK 97929322 T DK97929322 T DK 97929322T DK 97929322 T DK97929322 T DK 97929322T DK 0934073 T3 DK0934073 T3 DK 0934073T3
Authority
DK
Denmark
Prior art keywords
infections
treatment
heliobacter
preparing
pharmaceutical composition
Prior art date
Application number
DK97929322T
Other languages
English (en)
Inventor
Hannu Korhonen
Eeva-Liisa Syvaeoja
Erkki Vasara
Timo Kosunen
Pertti Marnila
Original Assignee
Valio Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI962688A external-priority patent/FI962688A0/fi
Priority claimed from FI962687A external-priority patent/FI962687A0/fi
Application filed by Valio Oy filed Critical Valio Oy
Application granted granted Critical
Publication of DK0934073T3 publication Critical patent/DK0934073T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK97929322T 1996-06-28 1997-06-30 Farmaceutisk sammensætning indeholdende komplementproteiner til behandling af Heliobacter infektioner og en fremgangsmåde til fremstilling af sammensætningen DK0934073T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI962688A FI962688A0 (fi) 1996-06-28 1996-06-28 Metod och produkt foer behandling av helikobakterieinfektioner
FI962687A FI962687A0 (fi) 1996-06-28 1996-06-28 Foerfarande foer berikning av biologiskt aktiva proteiner fraon vassla av raomjoelk
PCT/FI1997/000418 WO1998000150A1 (en) 1996-06-28 1997-06-30 Pharmaceutical composition, comprising complement proteins, for the treatment of helicobacter infections and a method for the preparation of the composition

Publications (1)

Publication Number Publication Date
DK0934073T3 true DK0934073T3 (da) 2003-05-05

Family

ID=26160179

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97929322T DK0934073T3 (da) 1996-06-28 1997-06-30 Farmaceutisk sammensætning indeholdende komplementproteiner til behandling af Heliobacter infektioner og en fremgangsmåde til fremstilling af sammensætningen

Country Status (7)

Country Link
EP (1) EP0934073B1 (da)
AT (1) ATE232392T1 (da)
AU (1) AU3346197A (da)
DE (1) DE69719049T2 (da)
DK (1) DK0934073T3 (da)
ES (1) ES2192686T3 (da)
WO (1) WO1998000150A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5772999A (en) * 1996-07-30 1998-06-30 Dcv Biologics, L.P. Method of preventing, countering, or reducing NSAID-induced gastrointestinal damage by administering milk or egg products from hyperimmunized animals
DE102011008579A1 (de) * 2010-08-12 2012-02-16 Lr Health & Beauty Systems Gmbh Verfahren zur Herstellung eines Kolostrum-Produktes und Vorrichtung zur Durchführung des Verfahrens
ES2891149T3 (es) * 2013-12-13 2022-01-26 Saisei Pharma Co Ltd Composición farmacéutica que comprende un producto procesado con enzimas de calostro bovino

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61701B1 (en) * 1986-07-17 1994-11-30 Morinaga Milk Industry Co Ltd Process for producing bovine lactoferrin in high purity
EP0338229B1 (de) * 1988-04-19 1993-06-16 Biotest Pharma Gmbh Präparat mit Antikörperaktivität und breitem Wirkungsspektrum, daraus bestehende oder diese enthaltende Mittel und deren Verwendung zur Behandlung von bakteriell oder toxin-bedingten Erkrankungen und zur Bekämpfung von Protozoen
JPH04169539A (ja) * 1990-11-01 1992-06-17 Imuno Japan:Kk 消化器疾患治療・予防剤およびその製造方法
JPH05202098A (ja) * 1992-01-29 1993-08-10 Snow Brand Milk Prod Co Ltd 乳質原料から生理活性物質の製造法
DE69432309D1 (de) * 1993-09-20 2003-04-24 Anadis Ltd Verfahren zur herstellung von immunoglobulinen aus colostrum und deren verwendung in pharmazeutischen zusammensetzungen

Also Published As

Publication number Publication date
EP0934073A1 (en) 1999-08-11
EP0934073B1 (en) 2003-02-12
AU3346197A (en) 1998-01-21
ATE232392T1 (de) 2003-02-15
DE69719049T2 (de) 2003-12-18
ES2192686T3 (es) 2003-10-16
DE69719049D1 (de) 2003-03-20
WO1998000150A1 (en) 1998-01-08

Similar Documents

Publication Publication Date Title
DK1133238T3 (da) Fremgangsmåde til fremstilling af en proteinsammensætning og af en formulering til börn indeholdende den
DK160614C (da) Analogifremgangsmaade til fremstilling af vinblastinderivater og farmaceutisk acceptable salte deraf
ES8201827A1 (es) Procedimiento para pasteurizar una composicion que contiene una proteina termicamente sensible y terapeuticamente activa
BR9909472A (pt) Polipeptìdeo purificado, processo para prevenir tuberculose, e, composição farmacêutica
DK0548114T5 (da) Mometason-furoat-monohydrat, fremgangsmåde til fremtilling deraf og farmaceutiske præparater indeholdende dette
DK0754231T3 (da) Peptidfragment fra G-proteinet fra respiratorisk syncytialvirus, immunogent middel, farmaceutisk præparat, der indeholder det, og fremgangsmåde til fremstilling deraf
DK442788D0 (da) Fremgangsmaade og praeparat til behandling af non-ige-medierede lidelser
DK1149905T3 (da) Fremgangsmåder og præparat til polypeptidteknologi
DE3469534D1 (en) Modified proteinase inhibitors, process for their preparation and pharmaceutical compositions containing them
IT1203873B (it) Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e
SG73894G (en) Pharmaceutical formulations containing melphalan or melphalan hydrochloride, as well as melphalan and melphalan hydro-chloride and processes for preparing them
IT1262993B (it) Complesso di bismuto citrato di ranitidina ed antibiotico, composizione che lo contiene e relativo metodo di produzione ed impiego
PL323048A1 (en) Multimeric recombined ureazeic vaccine
DK0934073T3 (da) Farmaceutisk sammensætning indeholdende komplementproteiner til behandling af Heliobacter infektioner og en fremgangsmåde til fremstilling af sammensætningen
IT8324018A0 (it) Procedimento per preparare l-carnitina e intermedi chimici impiegati in tale procedimento.
DK177990A (da) Mono-(2-ammonium-2-hydroxymethyl-1,3-propandiol)(2r,cis)-1,2-epoxypropylphosphonat, fremgangsmaade til fremstilling deraf og faste farmaceutiske praeparater indeholdende forbindelsen
DK1037539T3 (da) Fremgangsmåde til forögelse af et proteins fordöjelseshastighed og modificeret proteinprodukt
NO971518L (no) Fremgangsmåte for fremstilling av forsterket antigenisk Heliobacter sp. og vaksiner inneholdende disse
CA2047843A1 (en) Method and product for the treatment of gastric disease
IT8719700A0 (it) 2-tiometil-sostituite-piridine, metodo per la loro preparazione e composizioni farmaceutiche che le contengono.
DK0942921T3 (da) Forögede udbytter af krystalliseret protein ved anvendelse af et fast adsorptionsmateriale
NO912822D0 (no) Fremgangsmaate for fremstilling av klasse ii-proteinet frayttermembranen til neisseria meningitidis.
NO964252D0 (no) Anvendelsen av spiramycin for behandling av gastrointestinale mangler som forårsaket av H.pylori
DK4683D0 (da) Fremgangsmade og apparat til at vende mejeriprodukter, isaer oste
NO912824L (no) Fremgangsmaate for fremstilling av klasse ii-proteinet frayttermembranen til neisseria meningitidis.